1. Home
  2. ALLR vs BTBD Comparison

ALLR vs BTBD Comparison

Compare ALLR & BTBD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALLR
  • BTBD
  • Stock Information
  • Founded
  • ALLR 2004
  • BTBD 1987
  • Country
  • ALLR United States
  • BTBD United States
  • Employees
  • ALLR N/A
  • BTBD N/A
  • Industry
  • ALLR Biotechnology: Pharmaceutical Preparations
  • BTBD Restaurants
  • Sector
  • ALLR Health Care
  • BTBD Consumer Discretionary
  • Exchange
  • ALLR Nasdaq
  • BTBD Nasdaq
  • Market Cap
  • ALLR 15.8M
  • BTBD 13.0M
  • IPO Year
  • ALLR N/A
  • BTBD 2021
  • Fundamental
  • Price
  • ALLR $1.73
  • BTBD $1.91
  • Analyst Decision
  • ALLR Strong Buy
  • BTBD
  • Analyst Count
  • ALLR 1
  • BTBD 0
  • Target Price
  • ALLR $9.25
  • BTBD N/A
  • AVG Volume (30 Days)
  • ALLR 641.5K
  • BTBD 932.2K
  • Earning Date
  • ALLR 11-13-2025
  • BTBD 11-12-2025
  • Dividend Yield
  • ALLR N/A
  • BTBD N/A
  • EPS Growth
  • ALLR N/A
  • BTBD N/A
  • EPS
  • ALLR N/A
  • BTBD N/A
  • Revenue
  • ALLR N/A
  • BTBD $14,533,449.00
  • Revenue This Year
  • ALLR N/A
  • BTBD N/A
  • Revenue Next Year
  • ALLR N/A
  • BTBD N/A
  • P/E Ratio
  • ALLR N/A
  • BTBD N/A
  • Revenue Growth
  • ALLR N/A
  • BTBD 1.58
  • 52 Week Low
  • ALLR $0.61
  • BTBD $1.00
  • 52 Week High
  • ALLR $2.35
  • BTBD $5.60
  • Technical
  • Relative Strength Index (RSI)
  • ALLR 58.71
  • BTBD 50.33
  • Support Level
  • ALLR $1.54
  • BTBD $1.80
  • Resistance Level
  • ALLR $1.65
  • BTBD $2.15
  • Average True Range (ATR)
  • ALLR 0.13
  • BTBD 0.13
  • MACD
  • ALLR -0.01
  • BTBD 0.01
  • Stochastic Oscillator
  • ALLR 72.97
  • BTBD 53.20

About ALLR Allarity Therapeutics Inc.

Allarity Therapeutics Inc is a clinical-stage, precision medicine pharmaceutical company focused on developing novel anti-cancer therapeutics for patients with high unmet medical needs. The company is actively advancing the development of stenoparib, an orally available, small-molecule inhibitor for patients with advanced recurrent ovarian cancer. It is leveraging its proprietary Drug Response Predictor (DRP) technology to refine patient selection and improve clinical outcomes. The company operates as a single operating and reporting segment (developing a treatment for ovarian cancer) in two geographic areas: Denmark and the United States.

About BTBD BT Brands Inc.

BT Brands Inc operates and owns a fast-food restaurant called Burger Time. The company also operates in Minnesota as a franchisee of Dairy Queen. It offers a variety of burgers and other affordably priced foods such as chicken sandwiches, pulled pork sandwiches, chicken chunks, side dishes, and soft drinks.

Share on Social Networks: